The ABC's of Dopamine Receptor Partial Agonists - Aripiprazole, Brexpiprazole and Cariprazine | PDF | Psychiatric Diagnosis | Psychiatry
Full article: Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial
![A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. - Abstract - Europe PMC A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4601722/bin/schbul_sbv125_f0003.jpg)
A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. - Abstract - Europe PMC
![The ABC's of dopamine receptor partial agonists – aripiprazole, brexpiprazole and cariprazine: the 15‐min challenge to sort these agents out - Citrome - 2015 - International Journal of Clinical Practice - Wiley Online Library The ABC's of dopamine receptor partial agonists – aripiprazole, brexpiprazole and cariprazine: the 15‐min challenge to sort these agents out - Citrome - 2015 - International Journal of Clinical Practice - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/269f70d4-53b3-4d50-9da4-5125685de618/ijcp.2015.69.issue-11.cover.jpg)
The ABC's of dopamine receptor partial agonists – aripiprazole, brexpiprazole and cariprazine: the 15‐min challenge to sort these agents out - Citrome - 2015 - International Journal of Clinical Practice - Wiley Online Library
![A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. - Abstract - Europe PMC A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4601722/bin/schbul_sbv125_f0002.jpg)
A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. - Abstract - Europe PMC
![PDF) A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes | Natasha Bennett - Academia.edu PDF) A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes | Natasha Bennett - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/69448615/mini_magick20210912-2672-s4k8jw.png?1631446072)
PDF) A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes | Natasha Bennett - Academia.edu
![Hard-to-treat depression in seniors focus of $13.5 million study - The Source - Washington University in St. Louis Hard-to-treat depression in seniors focus of $13.5 million study - The Source - Washington University in St. Louis](https://source.wustl.edu/wp-content/uploads/2016/12/antidepressants-700x467.jpg)
Hard-to-treat depression in seniors focus of $13.5 million study - The Source - Washington University in St. Louis
![Pharmaceuticals | Free Full-Text | Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole Pharmaceuticals | Free Full-Text | Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00895/article_deploy/html/images/pharmaceuticals-15-00895-ag.png?1658368008)
Pharmaceuticals | Free Full-Text | Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole
![Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe - The Lancet Psychiatry Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/c235162f-9c32-440d-8264-f5bafad7a353/gr1.gif)
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe - The Lancet Psychiatry
![Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study - Journal of the American Academy of Child & Adolescent Psychiatry Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/aa8031ef-73da-460d-838b-232d8ff0b369/gr1_lrg.jpg)
Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study - Journal of the American Academy of Child & Adolescent Psychiatry
![Pharmaceuticals | Free Full-Text | Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole Pharmaceuticals | Free Full-Text | Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00895/article_deploy/html/images/pharmaceuticals-15-00895-g003.png?1658368003)
Pharmaceuticals | Free Full-Text | Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole
![Cariprazine in Acute Exacerbation of Schizophrenia: A Fixed-Dose, Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Trial | Psychiatrist.com Cariprazine in Acute Exacerbation of Schizophrenia: A Fixed-Dose, Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Trial | Psychiatrist.com](https://www.psychiatrist.com/PublishingImages/v76n1201T1.gif)